
Investors Are Buzzing About This AI Stock That Even Jim Cramer Got Wrong
Jim Cramer, known for his insightful stock picks and market predictions, recently shared his thoughts on Recursion Pharmaceuticals Inc (NASDAQ:RXRX) in one of his programs. Despite his initial enthusiasm about Recursion, especially noting Nvidia’s investment in the company, Cramer admitted he might